Roche Holding Management

Management criteria checks 2/4

Roche Holding's CEO is Thomas Schinecker, appointed in Mar 2023, has a tenure of 1.67 years. directly owns 0% of the company’s shares, worth €1.02M. The average tenure of the management team and the board of directors is 4.8 years and 7.7 years respectively.

Key information

Thomas Schinecker

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownership0.0004%
Management average tenure4.8yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Thomas Schinecker's remuneration changed compared to Roche Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CHF 11b

Mar 31 2024n/an/a

CHF 11b

Dec 31 2023n/an/a

CHF 11b

Sep 30 2023n/an/a

CHF 11b

Jun 30 2023n/an/a

CHF 11b

Mar 31 2023n/an/a

CHF 12b

Dec 31 2022CHF 5mCHF 1m

CHF 12b

Sep 30 2022n/an/a

CHF 14b

Jun 30 2022n/an/a

CHF 15b

Mar 31 2022n/an/a

CHF 14b

Dec 31 2021CHF 4mCHF 1m

CHF 14b

Sep 30 2021n/an/a

CHF 14b

Jun 30 2021n/an/a

CHF 14b

Mar 31 2021n/an/a

CHF 14b

Dec 31 2020CHF 4mCHF 879k

CHF 14b

Sep 30 2020n/an/a

CHF 14b

Jun 30 2020n/an/a

CHF 13b

Mar 31 2020n/an/a

CHF 13b

Dec 31 2019CHF 2mCHF 609k

CHF 13b

Compensation vs Market: Insufficient data to establish whether Thomas's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Thomas's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Thomas Schinecker (49 yo)

1.7yrs

Tenure

CHF 5,335,592

Compensation

Dr. Thomas Schinecker serves as Chairman of the Board at Genentech, Inc. since March 2023. He serves as Chief Executive Officer at Roche Holding AG since March 15, 2023. He has been Chief Executive Officer...


Leadership Team

NamePositionTenureCompensationOwnership
Severin Schwan
Executive Chairman11.7yrsCHF 11.48m0.043%
€ 97.8m
Thomas Schinecker
Chief Executive Officer1.7yrsCHF 5.34m0.00045%
€ 1.0m
Alan Hippe
Chief Financial & Information Officer13.6yrsCHF 6.05m0.0063%
€ 14.3m
Bruno Eschli
Head of Investor Relationsno datano datano data
Claudia Bockstiegel
General Counsel4.6yrsno datano data
Pascale Schmidt
Chief Compliance Officer4.8yrsno datano data
Barbara Schadler
Head of Group Communications5.1yrsno datano data
Cristina Wilbur
Chief People Officer8.7yrsCHF 4.25m0.0020%
€ 4.6m
Nicolas Dunant
Head of Group Media Relationsno datano datano data
Boris Zaitra
Head of Corporate Business Developmentno datano datano data
Paulo Fontoura
Head of Neuroscience Clinical Developmentno datano datano data
Johannes Clevers
Head of Roche Pharma Research & Early Development2.7yrsCHF 82.50kno data

4.8yrs

Average Tenure

57yo

Average Age

Experienced Management: RHO6's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Severin Schwan
Executive Chairman11.7yrsCHF 11.48m0.043%
€ 97.8m
Bernard Poussot
Non-Executive Independent Director9.8yrsCHF 330.00k0.00013%
€ 295.6k
Ulf Schneider
Director1.7yrsno data0.00063%
€ 1.4m
Andre Hoffmann
Independent Vice Chairman28.8yrsCHF 402.82k3.53%
€ 8.0b
Patrick Frost
Independent Non Executive Director4.7yrsCHF 360.00k0.00025%
€ 568.5k
Richard Lifton
Non-Executive Independent Director9.8yrsCHF 346.71k0%
€ 0
Anita Hauser
Non-Executive Independent Director7.7yrsCHF 336.16k0.00040%
€ 909.6k
Jorg Duschmale
Non-Executive Independent Director4.7yrsCHF 364.59kno data
Akiko Iwasaki
Director1.7yrsno datano data
Claudia Ricarda Suessmuth Dyckerhoff
Non-Executive Independent Director8.7yrsCHF 367.02k0.00034%
€ 773.1k
Jemilah Mahmood
Independent Non-Executive Director2.7yrsCHF 272.50kno data

7.7yrs

Average Tenure

57yo

Average Age

Experienced Board: RHO6's board of directors are considered experienced (7.7 years average tenure).